Article info
Therapeutics/Prevention
Randomised controlled trial
Artemisinin-based combination therapy (ACT) versus atovaquone-proguanil: do not choose between but, rather, combine them
- Correspondence to : Professor Eli Schwartz, The Chaim Sheba Medical Center, The Center for Geographic Medicine, Tel Hashomer 52621, Israel; elischwa{at}post.tau.ac.il
Citation
Artemisinin-based combination therapy (ACT) versus atovaquone-proguanil: do not choose between but, rather, combine them
Publication history
- First published January 12, 2016.
Online issue publication
March 22, 2016
Article Versions
- Previous version (12 January 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/